Spacelabs Healthcare, Inc. recalls Spacelabs Healthcare Smart Disclosure System, Model 92810, a component of the Intesys Clinical Suite (ICS) G2.
- Recall date
- January 28, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2035-2019
- FDA classification
- Class II
- Brand / firm
- Spacelabs Healthcare, Inc.
- Sold / distributed
- Distribution was nationwide. There was also government and military distribution. Foreign distribution was made to Argentina, Bahrain, Bolivia, Brazil, Canada, Cayman Islands, Chile, China, Costa Rica, Czech Republic, France, Hong Kong, India, Indonesia, Italy, Kuwait, Malaysia, Mexico, Netherlands…
Why it was recalled
Several reports were received that patient records were printed with the correct patient demographics but containing another patient's waveforms.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Spacelabs Healthcare Smart Disclosure System, Model 92810, a component of the Intesys Clinical Suite (ICS) G2.
Get recall alerts
Free email alert whenever Spacelabs Healthcare, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Spacelabs Healthcare, Inc.